Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation.
暂无分享,去创建一个
Alfred P. Hallstrom | Peter J. Kudenchuk | Michele Olsufka | Michael K. Copass | Leonard A. Cobb | Richard O. Cummins | Carol Fahrenbruch | Alidene Doherty | William A. Murray | Thomas R. Walsh
[1] C. Case,et al. Rhythm changes during resuscitation from ventricular fibrillation. , 1993, Resuscitation.
[2] Effect of injection site on circulation times during cardiac arrest. , 1988, Critical care medicine.
[3] P. Kowey,et al. Dose-Ranging Study of Intravenous Amiodarone in Patients With Life-Threatening Ventricular Tachyarrhythmias , 1995 .
[4] M. Copass,et al. Considerations for improving survival from out-of-hospital cardiac arrest. , 1986, Annals of emergency medicine.
[5] A. Choussat,et al. [Hemodynamic effects of intravenous amiodarone in humans]. , 1977, Archives des maladies du coeur et des vaisseaux.
[6] E. Harrison. Lidocaine in prehospital countershock refractory ventricular fibrillation. , 1981, Annals of emergency medicine.
[7] A. Jaffe. The use of antiarrhythmics in advanced cardiac life support. , 1993, Annals of emergency medicine.
[8] W. Weaver. Resuscitation outside the hospital--what's lacking? , 1991, The New England journal of medicine.
[9] A. Hallstrom,et al. COMMUNITY‐BASED CARDIOPULMONARY RESUSCITATION: WHAT HAVE WE LEARNED? * , 1982, Annals of the New York Academy of Sciences.
[10] C. Emerman,et al. The effect of bolus injection on circulation times during cardiac arrest. , 1990, The American journal of emergency medicine.
[11] H. Refsum,et al. Acute electrophysiologic and blood pressure effects of amiodarone and its solvent in the dog. , 2009, Acta pharmacologica et toxicologica.
[12] N. El-Sherif,et al. Hypotensive Action of Commercial Intravenous Amiodarone and Polysorbate 80 in Dogs , 1982, Journal of cardiovascular pharmacology.
[13] L. Bossaert,et al. Guidelines for advanced life support , 1992 .
[14] J. Darin,et al. A randomized comparison study of bretylium tosylate and lidocaine in resuscitation of patients from out-of-hospital ventricular fibrillation in a paramedic system. , 1984, Annals of emergency medicine.
[15] R. Nowak,et al. Bretylium tosylate as initial treatment for cardiopulmonary arrest: randomized comparison with placebo. , 1981, Annals of emergency medicine.
[16] C. Weston,et al. Predicting survival from out-of-hospital cardiac arrest: a multivariate analysis. , 1997, Resuscitation.
[17] M. Copass,et al. Comparison of bretylium tosylate and lidocaine in management of out of hospital ventricular fibrillation: a randomized clinical trial. , 1981, The American journal of cardiology.
[18] M. Copass,et al. Community-based interventions for sudden cardiac death. Impact, limitations, and changes. , 1992, Circulation.
[19] E. Fain,et al. Lidocaine causes a reversible, concentration-dependent increase in defibrillation energy requirements. , 1986, Journal of the American College of Cardiology.
[20] T R Fleming,et al. Designs for group sequential tests. , 1984, Controlled clinical trials.
[21] J. A. Weigel,et al. Initial treatment of ventricular fibrillation: defibrillation or drug therapy. , 1988, The American journal of emergency medicine.
[22] M. Niebauer,et al. The effect of newer antiarrhythmic drugs on defibrillation threshold , 1980, Critical care medicine.
[23] P. Kowey,et al. Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Group. , 1995, Circulation.
[24] L. Geddes,et al. Elevation of ventricular defibrillation threshold in dogs by antiarrhythmic drugs. , 1979, American heart journal.
[25] R. Kerber,et al. Effect of lidocaine and bretylium on energy requirements for transthoracic defibrillation: experimental studies. , 1986, Journal of the American College of Cardiology.
[26] D. Fatovich,et al. Magnesium in cardiac arrest (the magic trial). , 1997, Resuscitation.
[27] R. Grolleau,et al. A randomized hemodynamic comparison of intravenous amiodarone with and without Tween 80. , 1988, European heart journal.
[28] M. Lehmann,et al. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs , 1993 .
[29] I. Stiell,et al. Do advanced cardiac life support drugs increase resuscitation rates from in-hospital cardiac arrest? The OTAC Study Group. , 1998, Annals of emergency medicine.
[30] D. Echt,et al. Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs. Sodium channel block and action potential prolongation. , 1989, Circulation.
[31] M. Copass,et al. Effect of epinephrine and lidocaine therapy on outcome after cardiac arrest due to ventricular fibrillation. , 1990, Circulation.
[32] R. Gillum,et al. Sudden coronary death in the United States: 1980-1985. , 1989, Circulation.
[33] J. Han,et al. Effect of procainamide on fibrillation threshold of normal and ischemic ventricles. , 1974, The American journal of cardiology.
[34] A. Laupacis,et al. Association of drug therapy with survival in cardiac arrest: limited role of advanced cardiac life support drugs. , 1995, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[35] K. Nademanee,et al. The historical development, cellular electrophysiology and pharmacology of amiodarone. , 1989, Progress in cardiovascular diseases.
[36] L. Ekström,et al. Lidocaine in out-of-hospital ventricular fibrillation. Does it improve survival? , 1997, Resuscitation.
[37] M. Copass,et al. Amplitude of ventricular fibrillation waveform and outcome after cardiac arrest. , 1985, Annals of internal medicine.
[38] B. White,et al. Peripheral vs central circulation times during CPR: a pilot study. , 1981, Annals of emergency medicine.
[39] R. Califf,et al. Randomised trial of magnesium in in-hospital cardiac arrest , 1997, The Lancet.